太原大便拉出血怎么回事太原大便出血 肚子疼,山西开痔疮哪里好,山西痔疮做什么运动,山西肛周那家医院,太原肛裂必须做手术吗,山西肛肠科总医院,山西为何大便时带血

NEW YORK, Oct. 3 (Xinhua) -- For the 34-year-old Alexis Steinman, Oct. 3 would have been a great day, because her father Ralph Steinman was announced winner of the 2011 Nobel Prize in Physiology or Medicine.But as she talked to Xinhua at the Rockefeller University where his father worked, she said the day was rather "bittersweet"."This is the moment, but my Dad was not here," said Alexis, trying to hold her tears.The Canadian-born cell biologist Ralph Steinman died of pancreatic cancer on Friday at the age of 68, three days before he was announced the joint winner along with Prof. Bruce Beutler and Prof. Jules Hoffman for the Nobel Prize in Physiology or Medicine."We even talked about the Nobel Prize days before his death," Alexis added."We were like 'OK Dad, I know things aren't going well but the Nobel, they are going to announce it next Monday'. And he was like 'I know I have got to hold out for that. They don't give it to you if you have passed away,'" she said."It's really impossible to describe how our family is feeling right now. We're devastated to have lost Ralph,"Steinman' s son Adam Steinman told reporters at the press conference at Rockefeller University. "We're so incredibly proud of Dad for receiving this wonderful honor ... We know he will live on through his scientific contributions," he said.Rockefeller University president Marc Tessier-Lavigne told reporters during Monday's press conference that the university only heard of Steinman's death from the family about half an hour after news of the Nobel prize came out from Sweden."We are all deeply saddened by his death, " said Tessier- Lavigne , adding that Steinman had been treating himself with a groundbreaking therapy based on his research into the body's immune system.He said Steinman's research has laid the foundation for numerous discoveries in the critically important field of immunology, and it has led to innovative new approaches in how people treat cancer, infectious diseases and disorders of the immune system.Steinman's first student and close colleague Michel Nussenzweig told the press conference packed with reporters, students and professors that "one of the interesting things about Ralph and his discovery is that no one believes it for a really long time.""What was amazing about Ralph was that he just knew that, even though nobody else believed it, this was really important, and he persisted, and finally after a very long time, everyone just found out it was true," Nussenzweig said."Ralph worked until last week. His dream was to use his discovery to make vaccines and it is a dream that is pretty close, and we are all continuing to work to make that come true," he added.The Nobel Foundation made a statement after learning Steinman's death, saying that the decision to award the prize to the Canadian scientist would remain unchanged despite his death, and the prize money will be transferred to his estate.

BEIJING, Nov. 30 (Xinhua) -- China's efforts to fight AIDS are impressive and its experience can be shared, according to Michel Sidibe, executive director of the Joint United Nations Programme on HIV/AIDS (UNAIDS)."We have seen progress in terms of new infections. The number of people going into treatment is increasing and the mortality rate is going down very quickly in China," Sidibe said during an interview with Xinhua on Wednesday.Sidibe said he was impressed by the country's political leadership and commitment to controlling AIDS.According to UNAIDS, the country has reported a 60-percent reduction in deaths due to AIDS over the past eight years.New HIV infection cases in China have been reduced from 70,000 people annually in 2005 to around 48,000 in 2011, according to the country's health department."However, China's success will not only be measured by what it has done for the Chinese people," Sidibe said.China has successful experience in reducing new HIV infections among intravenous drug users, which can be shared with the rest of the world, particularly east Europe and south Asia where HIV infections among drug abusers is a major challenge, he said.Sidibe suggested that the country should work with the rest of the developing world, particularly Africa, in fighting AIDS.A partnership between China and Africa will make a "big, big difference" in reducing AIDS mortality rates and introducing new technology and perspectives in Africa, said the official who had worked for UN in several African countries for more than two decades.Admitting the challenges of funding AIDS control programs during the current global economic downturn, Sidibe called for global solidarity and increasing shared responsibilities among countries."It is a critical moment now. It is not a time to stop investment but to redouble our efforts, to make sure that we will continue to make progress in the fight against HIV," Sidibe said."Getting to Zero" has been chosen as the main theme of World AIDS Day for the next five years, referring to UNAIDS' vision of "zero new HIV infections, zero discrimination and zero AIDS-related deaths."Sidibe met with Li Congjun, president of the Xinhua News Agency, on Wednesday before the interview. The agency has launched a global media campaign in cooperation with UNAIDS to raise public awareness about HIV/AIDS."The partnership (with Xinhua) is not only about writing news about HIV. It is about helping people to change their attitude and make decisions to help protect themselves," Sidibe said.

SAN FRANCISCO, Oct. 5 (Xinhua) -- Apple co-founder and longtime Chief Executive Officer Steve Jobs passed away on Wednesday."Steve died peacefully today surrounded by his family," Jobs' family said in a statement."We are grateful for the support and kindness of those who share our feelings for Steve. We know many of you will mourn with us, and we ask that you respect our privacy during our time of grief," said the statement.Apple's website has changed to "Steve Jobs: 1955-2011," along with the most iconic picture in which the scraggly bearded charismatic visionary posed with one hand up to his chin.Photo taken on Oct. 5, 2011 shows photo of Steve Jobs on the front page of www.apple.com. Apple Board of Directors announced that co-founder and former Chief Executive Officer Steve Jobs passed away on Wednesday"Apple has lost a visionary and creative genius, and the world has lost an amazing human being," the company said in a statement. "Those of us who have been fortunate enough to know and work with Steve have lost a dear friend and an inspiring mentor. Steve leaves behind a company that only he could have built and this spirit will forever be the foundation of Apple."Apple are asking for "thoughts, memories and condolences" to be shared by emailing rememberingsteve@apple.com.Apple Board of Directors also said in a statement that "Steve's brilliance, passion and energy were the source of countless innovations that enrich and improve all of our lives. The world is immeasurably better because of Steve."According to a memo sent by CEO Tim Cook, Apple is planning a celebration of Jobs' life for employees that will take place soon.Jobs took a medical leave of absence earlier this year, the third in his battle with pancreatic cancer that began in 2004. On Aug. 24, he stepped down as Apple CEO, saying "I have always said if there ever came a day when I could no longer meet my duties and expectations as Apple's CEO, I would be the first to let you know. Unfortunately, that day has come."Jobs recommended former CEO Tim Cook take his place as CEO. On Tuesday, Cook gave his first product announcement as CEO unveiling the new iPhone 4S.

WASHINGTON, Nov. 24 (Xinhua) -- An inexpensive drug that treats Type 2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. The research, led by pediatrics professor James Trosko and colleagues from South Korea's Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type 2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers.The research appeared online this week in PLoS One.For the study, Trosko and colleagues focused on the concept that cancers originate from adult human stem cells and that there are many natural and man-made chemicals that enhance the growth of breast cancer cells. Using culture dishes, they grew miniature human breast tumors, or mammospheres, that activated a certain stem cell gene. Then the mammospheres were exposed to natural estrogen -- a known growth factor and potential breast tumor promoter -- and man-made chemicals that are known to promote tumors or disrupt the endocrine system.The team found that estrogen and the chemicals caused the mammospheres to increase in numbers and size. However, with metformin added, the numbers and size of the mammospheres were dramatically reduced. While each of the chemicals enhanced growth by different means, metformin seemed to be able to inhibit their stimulated growth in all cases."While future studies are needed to understand the exact mechanism by which metformin works to reduce the growth of breast cancers, this study reveals the need to determine if the drug might be used as a preventive drug and for individuals who have no indication of any existing cancers," Trosko said.

BEIJING, Jan. 7 (Xinhua) -- The two-day National Financial Work Conference concluded Saturday, laying out development plans for the financial sector in the coming five years, according to a statement released after the meeting.Chinese Premier Wen Jiabao was present at the conference and delivered a keynote speech.Such a conference is held every five years. Similar meetings were held in 1997, 2002 and 2007.